Yahoo! Finance: MATK News

MARTEK BIOSCIENCES CORP Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online)

Tue, 29 Dec 2009 21:06:24 Etc/GMT

Backtesting a Value Strategy (at Seeking Alpha)

Tue, 29 Dec 2009 14:50:21 Etc/GMT

New Star Analyst Rankings for Martek Biosciences Corporation (StarMine)

Thu, 17 Dec 2009 14:35:17 Etc/GMT

Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript (at Seeking Alpha)

Thu, 17 Dec 2009 01:51:08 Etc/GMT

Martek Biosciences sales dip but profit increases to $11M (at bizjournals.com)

Thu, 17 Dec 2009 00:05:09 Etc/GMT

Earnings roundup: Hovnanian, Paychex (AP)

Wed, 16 Dec 2009 23:11:55 Etc/GMT

Among the earnings stories for Wednesday, Dec. 16, from AP Financial News: Top stories: RED BANK, N.J. -- Hovnanian Enterprises Inc. cut its loss in its latest quarter and saw orders for new homes rise for the fourth quarter in a row.

Options Traders Bet Dana, TiVo Will Drop (at TheStreet.com)

Wed, 16 Dec 2009 23:11:04 Etc/GMT

Martek 4Q profit rises 5 percent on lower costs (AP)

Wed, 16 Dec 2009 21:49:00 Etc/GMT

Martek Biosciences Corp., which sells infant formula and dietary supplements, said Wednesday its fiscal 2009 fourth-quarter profit rose 5 percent as better margins and a dip in expenses offset a sales decline.

Martek Announces Fourth Quarter and FY 2009 Financial Results (PR Newswire)

Wed, 16 Dec 2009 21:05:00 Etc/GMT

Martek Biosciences Corporation today announced its financial results for the fourth quarter and fiscal year ended October 31, 2009. Revenues for the fourth quarter were $87.6 million, down 3% from $90.4 million in the fourth quarter of fiscal 2008.

Prospecting for Winning Biotechs: Gilead Sciences (at Motley Fool)

Thu, 3 Dec 2009 20:21:36 Etc/GMT

Martek to Announce Fourth Quarter and Fiscal Year 2009 Results (PR Newswire)

Wed, 2 Dec 2009 21:00:00 Etc/GMT

Martek Biosciences Corporation announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approximately 4:00 p.m. Eastern Time .

Lightning Round OT: Martek Biosciences, Valmont Industries and More (at CNBC)

Fri, 20 Nov 2009 01:23:55 Etc/GMT

Algae Biofuels Have a Promising Future (at Seeking Alpha)

Fri, 13 Nov 2009 05:57:42 Etc/GMT

Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst (Wall Street Transcript)

Tue, 20 Oct 2009 21:25:00 Etc/GMT

67 WALL STREET, New York - October 20, 2009 - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

MARTEK BIOSCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)

Fri, 18 Sep 2009 16:26:50 Etc/GMT

MARTEK BIOSCIENCES CORP Financials (EDGAR Online Financials)

Thu, 17 Sep 2009 13:04:26 Etc/GMT

MARTEK BIOSCIENCES CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online)

Wed, 9 Sep 2009 21:01:38 Etc/GMT

MARTEK BIOSCIENCES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E (EDGAR Online)

Wed, 2 Sep 2009 20:09:37 Etc/GMT

One Nutritional Supplement That Works (at Forbes.com)

Fri, 21 Aug 2009 14:11:32 Etc/GMT

Vitamin F For Failure (at Forbes.com)

Thu, 20 Aug 2009 20:01:50 Etc/GMT